Knee Osteoarthritis & Weight Loss Research Study

Study ID: J2A-MC-GZPT

What is this study about?
This Phase 3 study is evaluating Orforglipron, a once-daily oral GLP-1 medication, to see whether it can help reduce knee pain from osteoarthritis while also supporting weight loss.

Who might be a good fit?
Adults with obesity and moderate knee pain related to knee osteoarthritis may be a good fit. Participants should not have diabetes and must be willing to pause specific medications used for knee pain during the study.

Why participate?
Participants receive regular health monitoring during scheduled visits, along with support for knee pain, weight management, and lifestyle guidance while helping advance future treatments.

Type 2 Diabetes Research Study for People Not Reaching A1c Goals

Study ID: J1R-MC-GZFD

What is this study about?
This Phase 2 study is evaluating an injectable medication similar to GLP-1 therapies to see whether it can help lower A1c levels in people with Type 2 diabetes who have not reached their goals while taking Semaglutide or Tirzepatide.

Who might be a good fit?
Adults with Type 2 diabetes who are already taking a stable dose of Semaglutide or Tirzepatide but still have elevated A1c levels may be a good fit.

Why participate?
Participants receive regular health monitoring during scheduled visits, along with support for diabetes management, weight management, and lifestyle guidance while helping advance future treatments.

Lower Back Pain & Weight Loss Research Study

Study ID: J1I-MC-GZQD

What is this study about?
This Phase 3 study is evaluating Retatrutide, a once-weekly injectable GLP-1 medication, to see whether it can help reduce lower back pain while also supporting weight loss in adults with obesity.

Who might be a good fit?
Adults with obesity and ongoing lower back pain may be a good fit. Participants should not have diabetes, must be willing to pause specific medications used for pain during the study, also must be comfortable undergoing MRI scans.

Why participate?
Participants receive regular health monitoring during scheduled visits, along with support for lower back pain, weight management, and lifestyle guidance while helping advance future treatments.

Weight Loss Research Study Using Retatrutide (Adult)

Study ID: J1I-MC-GZQL

What is this study about?
This Phase 3 study is evaluating Retatrutide, a once-weekly injectable GLP-1 medication. Researchers are studying different dose escalation schedules to better understand how gradually increasing the dose over time may support weight loss in adults with obesity.

Who might be a good fit?
Adults with obesity who do not have diabetes may be a good fit for this study.

Why participate?
Participants receive regular health monitoring during scheduled visits, along with support for weight management and lifestyle guidance while helping advance future treatments.

Weight Loss Research Study Using Eloranlintide (Adult)

Study ID: J3R-MC-YDAG

What is this study about?
This Phase 3 study is evaluating Eloralintide, a once-weekly injectable medication, to see whether it can help support weight loss in adults living with obesity.

Who might be a good fit?
Adults with obesity who do not have diabetes may be a good fit for this study.

Why participate?
Participants receive regular health monitoring during scheduled visits, along with support for weight management and lifestyle guidance while helping advance future treatments.

Cardiovascular Risk Research Study